ATC code J

Pharmaceutical drug classification

ATC code J: Antiinfectives for systemic use
J01 Antibacterials for systemic use J02 Antimycotics for systemic use J04 Antimycobacterials J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use QJ54 Antimycobacterials for intramammary use
Other ATC codes
A B C D G H QI J L M N P R S V

ATC code J Antiinfectives for systemic use is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3]^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ.^[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

References

[edit ]

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health . Retrieved 1 February 2020.
^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization . Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code J". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QJ". WHO Collaborating Centre for Drug Statistics Methodology.

v t e Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
gastrointestinal tract / metabolism (A)	stomach acid Antacids H₂ antagonists Proton-pump inhibitors Antiemetics Laxatives Antidiarrhoeals / Antipropulsives Anti-obesity drugs Diabetes medication Vitamins Dietary minerals
blood and blood forming organs (B)	Antithrombotics Antiplatelets Anticoagulants Thrombolytics / fibrinolytics Antihemorrhagics Platelets Coagulants Antifibrinolytics
cardiovascular system (C)	cardiac therapy / antianginals Cardiac glycosides Antiarrhythmics Cardiac stimulants Antihypertensives Diuretics Vasodilators Beta blockers Calcium channel blockers renin–angiotensin system ACE inhibitors Angiotensin II receptor antagonists Renin inhibitors Antihyperlipidemics Statins Fibrates Bile acid sequestrants
skin (D)	Emollients Cicatrizants Antipruritics Antipsoriatics Medicated dressings
genitourinary system (G)	Hormonal contraception Fertility agents Selective estrogen receptor modulators Sex hormones
endocrine system (H)	Hypothalamic–pituitary hormones Corticosteroids Glucocorticoids Mineralocorticoids Sex hormones Thyroid hormones / Antithyroid agents
infections and infestations (J, P, QI)	Antimicrobials: Antibacterials (Antimycobacterials) Antifungals Antivirals Antiparasitics Antiprotozoals Anthelmintics Ectoparasiticides Intravenous immunoglobulin Vaccines
malignant disease (L01–L02)	Anticancer agents Antimetabolites Alkylating Spindle poisons Antineoplastic Topoisomerase inhibitors
immune disease (L03–L04)	Immunomodulators Immunostimulants Immunosuppressants
muscles, bones, and joints (M)	Anabolic steroids Anti-inflammatories Non-steroidal anti-inflammatory drugs Antirheumatics Corticosteroids Muscle relaxants Bisphosphonates
brain and nervous system (N)	Analgesics Anesthetics General Local Anorectics Anti-ADHD agents Antiaddictives Anticonvulsants Antidementia agents Antidepressants Antimigraine agents Antiparkinson agents Antipsychotics Anxiolytics Aphrodisiacs Depressants Entactogens Entheogens Euphoriants Hallucinogens Psychedelics Dissociatives Deliriants Hypnotics / Sedatives Mood stabilizers Motivation-enhancing drug Neuroprotectives Nootropics Neurotoxins Orexigenics Serenics Stimulants Wakefulness-promoting agents
respiratory system (R)	Decongestants Bronchodilators Cough medicines H₁ antagonists
sensory organs (S)	Ophthalmologicals Otologicals
other ATC (V)	Antidotes Contrast media Radiopharmaceuticals Dressings Senotherapeutics
Drugs Pharmacological classification systems ATC codes Medicine portal

v
t
e

Antibacterials that inhibit protein synthesis (J01A, J01B, J01F, J01G, QJ01XQ)

30S

Aminoglycosides
(initiation inhibitors)

-mycin (Streptomyces )	Streptomycin ^# Dihydrostreptomycin Neomycin ^# Framycetin Paromomycin ^# Ribostamycin Kanamycin Amikacin ^# Arbekacin Bekanamycin Dibekacin Tobramycin (+loteprednol) Spectinomycin ^# Hygromycin B Totomycin Apramycin Nourseothricin
-micin (Micromonospora )	Gentamicin ^# Netilmicin Sisomicin Micronomicin Plazomicin ^# Isepamicin Verdamicin Astromicin
other	Butirosin

Tetracycline antibiotics
(tRNA binding)

Tetracyclines	Doxycycline ^# Chlortetracycline Clomocycline Demeclocycline Eravacycline Lymecycline Meclocycline ^‡ Metacycline Minocycline Omadacycline Oxytetracycline Penimepicycline Rolitetracycline Sarecycline Tetracycline ^#
Glycylcyclines	Tigecycline

50S

Oxazolidinone
(initiation inhibitors)

Peptidyl transferase

Amphenicols	Chloramphenicol ^# Azidamfenicol Thiamphenicol Florfenicol

MLS (transpeptidation/translocation)

Macrolides	Boromycin Carbomycin Carrimycin Clarithromycin ^# Dirithromycin Erythromycin ^# Flurithromycin Josamycin Kitasamycin Midecamycin Miocamycin Nafithromycin Oleandomycin Rokitamycin Roxithromycin Spiramycin Tildipirosin Tilmicosin Troleandomycin Tylosin Tylvalosin
Azalides	Azithromycin ^# Gamithromycin Tulathromycin
Ketolides	Telithromycin ^‡ Cethromycin Solithromycin ^†
Lincosamides	Clindamycin ^# Lincomycin Pirlimycin
Oxepanoprolinamides	Cresomycin Iboxamycin
Streptogramins	Pristinamycin (IA, IIA, IIB) NXL103 (Flopristin, Linopristin) Quinupristin/dalfopristin (Dalfopristin, Quinupristin) Streptogramin A Streptogramin B Virginiamycin (S1)

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

Antibacterials active on the cell wall and envelope (J01C-J01D)

β-lactams
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)

Penicillins (Penams)

Narrow
spectrum

β-lactamase sensitive (1st generation)	Benzylpenicillin (G) ^# Benzathine benzylpenicillin ^# Procaine benzylpenicillin ^# Phenoxymethylpenicillin (V) ^# Propicillin ^‡ Pheneticillin ^‡ Azidocillin ^‡ Clometocillin ^‡ Penamecillin ^‡
β-lactamase resistant (2nd generation)	Cloxacillin ^# (Dicloxacillin Flucloxacillin) Oxacillin Nafcillin Methicillin ^‡

Extended
spectrum

Aminopenicillins (3rd generation)	Amoxicillin ^# Ampicillin ^# (Pivampicillin Hetacillin ^‡ Bacampicillin ^‡ Lenampicillin Metampicillin ^‡ Talampicillin ^‡) Epicillin ^‡
Carboxypenicillins (4th generation)	Ticarcillin Carbenicillin ^‡ / Carindacillin ^‡ Temocillin ^‡
Ureidopenicillins (4th generation)	Piperacillin Azlocillin ^‡ Mezlocillin ^‡
Other	Mecillinam (Pivmecillinam) Sulbenicillin ^‡

Carbapenems / Penems

Cephems
Cephalosporins
Cephamycins
Carbacephems

1st generation	Cefazolin ^# Cefalexin ^# Cefadroxil Cefapirin Cefazedone ^‡ Cefazaflur ^‡ Cefradine ^‡ Cefroxadine ^‡ Ceftezole ^‡ Cefaloglycin ^‡ Cefacetrile ^‡ Cefalonium ^‡ Cefaloridine ^‡ Cefalotin Cefatrizine ^‡
2nd generation	Cefaclor Cefprozil Cefuroxime Cefuroxime axetil Cefamandole ^‡ Cefonicid ^‡ Ceforanide ^‡ Cefuzonam ^‡ Cephamycin (Cefoxitin Cefotetan Cefminox ^‡ Cefbuperazone ^‡ Cefmetazole ^‡) Carbacephem (Loracarbef ^‡)
3rd generation	Cefixime ^# Ceftriaxone ^# Cefotaxime ^# Antipseudomonal (Ceftazidime ^# Cefoperazone) Cefdinir Cefcapene Cefdaloxime Ceftizoxime Cefmenoxime Cefpiramide Cefpodoxime Ceftibuten Cefditoren Cefotiam ^‡ Cefetamet ^‡ Cefodizime ^‡ Cefpimizole ^‡ Cefsulodin ^‡ Cefteram ^‡ Ceftiolene ^‡ Oxacephem (Flomoxef Latamoxef ^‡)
4th generation	Cefepime Cefozopran ^‡ Cefpirome Cefquinome ^‡
5th generation	Ceftaroline fosamil Ceftolozane Ceftobiprole
Siderophore	Cefiderocol ^#
Veterinary	Ceftiofur Cefquinome Cefovecin

Monobactams

β-lactamase inhibitors

Combinations

Polypeptides

Lipopeptides	Insert into bacterial cell wall causing perforation and depolarization: Daptomycin Surfactin
Other	Inhibits PG elongation and crosslinking: Ramoplanin ^§

Intracellular

Inhibit PG subunit synthesis and transport: NAM synthesis inhibition
- Fosfomycin
DADAL/AR inhibitors
- Cycloserine
- Terizidone
bactoprenol inhibitors
- Bacitracin

Other

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

Antibacterials that inhibit nucleic acid (J01E, J01M)

Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)

DHFR inhibitor

2,4-Diaminopyrimidine
- Brodimoprim
- Iclaprim ^†
- Ormetoprim
- Pyrimethamine ^#
- Tetroxoprim
- Trimethoprim ^#

Sulfonamides
(DHPS inhibitor)

Short-acting	Sulfaisodimidine Sulfamethizole Sulfadimidine (Sulfamethazine, Sulfadimerazine, Sulfadimezine) Sulfapyridine (Sulfasalazine) Sulfafurazole (Acetyl sulfisoxazole) Sulfanilamide Prontosil Sulfathiazole (Phthalylsulfathiazole, Succinylsulfathiazole) Sulfathiourea
Intermediate-acting	Sulfamethoxazole Sulfadiazine ^# Sulfamoxole
Long-acting	Sulfadimethoxine Sulfadoxine Sulfalene Sulfametomidine Sulfametoxydiazine Sulfamethoxypyridazine Sulfaperin Sulfamerazine Sulfaphenazole Sulfamazone
Other/ungrouped	Mafenide Sulfacetamide Sulfaclozine Sulfadicramide Sulfaguanidine Sulfametrole Sulfanitran

Combinations

Other DHPS inhibitors

Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)

1st generation

Fluoroquinolones

2nd generation	Ciprofloxacin ^# Ofloxacin Enoxacin ^‡ Fleroxacin ^‡ Lomefloxacin ^‡ Nadifloxacin ^‡/Levonadifloxacin/Alalevonadifloxacin Norfloxacin ^‡ Pefloxacin ^‡ Rufloxacin ^‡
3rd generation	Levofloxacin ^# Balofloxacin ^‡ Grepafloxacin ^‡ Pazufloxacin ^‡ Sparfloxacin ^‡ Temafloxacin ^‡ Tosufloxacin ^‡
4th generation	Besifloxacin Delafloxacin Gatifloxacin Finafloxacin Gemifloxacin Moxifloxacin ^# Clinafloxacin ^† Garenoxacin ^‡ Prulifloxacin ^‡ Sitafloxacin ^‡ Trovafloxacin ^‡/Alatrofloxacin ^‡
Veterinary	Danofloxacin Difloxacin Enrofloxacin Ibafloxacin Marbofloxacin Orbifloxacin Pradofloxacin Sarafloxacin ^‡

Newer non-fluorinated

Related (DG)

Aminocoumarins: Novobiocin

Anaerobic DNA
inhibitors

Nitroimidazole derivatives	Secnidazole

RNA synthesis

Rifamycins/ RNA polymerase	Rifampicin ^# Rifabutin ^# Rifapentine ^# Rifaximin Rifalazil ^§
Lipiarmycins	Fidaxomicin

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v t e Antibacterials: others (J01X, D06AX)
Glycopeptides Lipoglycopeptides	Avoparcin Corbomycin Dalbavancin Oritavancin Ristocetin Teicoplanin Telavancin Vancomycin
Polymyxins	Colistin Polymyxin B
Steroid antibacterials	Fusidic acid
Imidazole derivatives	Metronidazole Ornidazole Tinidazole
Pleuromutilins	Azamulin Lefamulin Retapamulin Tiamulin Valnemulin
Nitrofuran derivatives	Furaltadone Furazolidone Nifuroxazide Nifurtoinol Nifurzide Nitrofurantoin Nitrofurazone
Other antibacterials	Bacitracin Clofoctol Daptomycin Fosfomycin Gepotidacin Linezolid Mandelic acid Methenamine Nitroxoline Novobiocin Spectinomycin Tedizolid Xibornol

v
t
e

Antifungals (D01 and J02)

Wall/
membrane

Ergosterol
inhibitors

Azoles (lanosterol 14α-
demethylase inhibitors)

Imidazoles	Topical: bifonazole ^‡ butoconazole chlormidazole ^‡ climbazole clotrimazole ^# croconazole ^‡ eberconazole econazole fenticonazole ^‡ flutrimazole isoconazole ketoconazole luliconazole miconazole ^# neticonazole ^‡ omoconazole ^‡ oxiconazole sertaconazole sulconazole tioconazole Systemic: ketoconazole
Triazoles	Topical: efinaconazole fluconazole ^# terconazole Systemic: fluconazole ^# fosfluconazole fosravuconazole hexaconazole ^‡ isavuconazole itraconazole ^# oteseconazole posaconazole voriconazole ^# Unknown: albaconazole ^‡ ravuconazole ^†
Thiazoles	Topical: abafungin ^‡

Polyene antimycotics
(ergosterol binding)

Topical: hamycin ^‡
natamycin
nystatin ^#
Systemic: amphotericin B ^#, hamycin^‡

Squalene monooxygenase
inhibitors

Allylamines	Topical: naftifine terbinafine Systemic: terbinafine
Benzylamines	Topical: butenafine

Others

Topical: amorolfine

β-glucan synthase
inhibitors

Intracellular

Pyrimidine analogues/ thymidylate synthase inhibitors	Systemic: flucytosine ^#
Mitotic inhibitors	Systemic: griseofulvin ^#
Aminoacyl tRNA synthetase inhibitors	Topical: tavaborole

Others

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04)

Nucleic acid inhibitor

Rifamycins/ RNA polymerase inhibitor	Rifampicin ^# Rifabutin Rifapentine Rifalazil ^§
Antifolates/DSI	Dapsone ^# Acedapsone Diucifon Promin Solasulfone Sulfoxone
ASA	4-Aminosalicylic acid ^# (Calcium aminosalicylate Sodium aminosalicylate)
Topoisomerase inhibitors/ quinolones	Gatifloxacin Moxifloxacin

Protein synthesis inhibitor

Aminoglycosides	Amikacin ^# Kanamycin Streptomycin ^#
Oxazolidone	Linezolid Sutezolid
Polypeptide antibiotics	Capreomycin

Cell envelope antibiotic

Peptidoglycan layer	Alanine analogue: Cycloserine ^#
Arabinogalactan layer	Ethylenediamine/arabinosyltransferase inhibitor: Ethambutol ^# SQ109 ^†
Mycolic acid layer	Hydrazides/mycolic acid synth. inhibition: Isoniazid ^# Methaniazide Thiocarbamides: Ethionamide ^# Prothionamide Thiocarlide Others/unsorted: Thioacetazone (amithiozone)

Other/unknown

Phenazine (Clofazimine)^#
Pyrazine (Pyrazinamide ^#, Morinamide)
Isoxazole (Terizidone)
Bedaquiline
Nitroimidazole (Delamanid , Pretomanid )

Combinations

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

DNA virus antivirals (primarily J05, also S01AD and D06BB)

Baltimore I

Herpesvirus

DNA-synthesis
inhibitor

TK activated

Purine analogue	guanine (Aciclovir ^#/Valaciclovir Ganciclovir/Valganciclovir ^# Penciclovir/Famciclovir) adenine (Vidarabine)
Pyrimidine analogue	uridine (Idoxuridine Trifluridine (+tipiracil) Edoxudine) thymine Brivudine FV-100 ^† Sorivudine ^‡ cytosine (Cytarabine)

Not TK activated

Foscarnet

Other

HPV/MC

Vaccinia

assembly: Rifampicin

Poxviridae

Hepatitis B (VII)

Nucleoside analogues/NARTIs: Entecavir ^#
Lamivudine
Lobucavir ^†
Telbivudine
Clevudine

Multiple/general

Nucleic acid inhibitors	Cidofovir Brincidofovir
Interferon	Interferon alfa 2b Peginterferon alfa-2a ^#
Multiple/unknown	Filociclovir ^† Ribavirin ^#/Taribavirin ^† Moroxydine

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

RNA virus antivirals (primarily J05, also S01AD and D06BB)

Hepatitis C

NS3/4A protease inhibitors (–previr)	Asunaprevir Boceprevir ^‡ Ciluprevir ^§ Danoprevir ^† Faldaprevir ^‡ Glecaprevir Grazoprevir Narlaprevir Paritaprevir Simeprevir Sovaprevir ^† Telaprevir ^‡ Vaniprevir Vedroprevir ^§ Voxilaprevir
NS5A inhibitors (–asvir)	Coblopasvir Daclatasvir ^# Elbasvir Ledipasvir Odalasvir ^† Ombitasvir Pibrentasvir Ravidasvir ^† Ruzasvir ^† Samatasvir ^† Velpatasvir
NS5B RNA polymerase inhibitors (–buvir)	Beclabuvir ^† Bemnifosbuvir ^† Dasabuvir ^# Deleobuvir ^§ Filibuvir ^§ GS-6620 ^§ IDX-184 ^§ Setrobuvir ^§ Sofosbuvir ^# Tegobuvir ^§ TMC-647055 ^§ Radalbuvir ^† Uprifosbuvir ^†
Combination drugs	Elbasvir/grazoprevir Glecaprevir/pibrentasvir Ledipasvir/sofosbuvir ^# Ombitasvir/paritaprevir/ritonavir ^# Sofosbuvir/daclatasvir Sofosbuvir/velpatasvir ^# Sofosbuvir/velpatasvir/voxilaprevir

Hepatitis D

Bulevirtide

Picornavirus

viral entry: Pleconaril ^†

Anti-influenza agents

neuraminidase inhibitors/release phase (Oseltamivir ^#
Zanamivir
Peramivir, Laninamivir ^†)

Multiple/general

Interferon	Interferon alfa 2b Peginterferon alfa-2a ^# Peginterferon alfa-2b ^#
3CL protease inhibitors (–trelvir)	Atilotrelvir Ensitrelvir ^† Ibuzatrelvir Leritrelvir Lufotrelvir Nirmatrelvir ^† (+ritonavir)^† Rupintrivir Simnotrelvir (+ritonavir ^†)
RNA pol inhibitors	CMX521 ^§ Deuremidevir ^† Favipiravir Galidesivir ^† GS-441524 ^§ Remdesivir MK-608 ^§ Mericitabine ^† Molnupiravir NITD008 ^§ Ribavirin ^# Taribavirin ^† Triazavirin Valopicitabine ^†
Multiple/Unknown/Other	EICAR ^§ Merimepodib ^§ Moroxydine Presatovir ^†

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

v
t
e

Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)

Capsid inhibitors

Lenacapavir (LEN)

Entry/fusion inhibitors
(Discovery and development)

gp41 (Enfuvirtide (ENF, T-20))^◊
CCR5 (Maraviroc (MVC)
Vicriviroc ^†, Cenicriviroc ^†, Leronlimab ^†)
CD4 (Ibalizumab (IBA), Semzuvolimab ^§)
gp120 (Fostemsavir (FTR))

Integrase inhibitors
(Integrase strand transfer inhibitors (INSTI))

Maturation inhibitors

Protease Inhibitors (PI)
(Discovery and development)

1^st generation	Amprenavir (APV) ^‡ Fosamprenavir (FPV) Indinavir (IDV) ^◊ Lopinavir (LPV) Nelfinavir (NFV) ^◊ Ritonavir (RTV) ^# Saquinavir (SQV) ^◊
2^nd generation	Atazanavir (ATV)°^# Darunavir (DRV)°^# Tipranavir (TPV) ^◊ TMC-310911 ^§

Reverse-transcriptase
inhibitors (RTIs)

Nucleoside and
nucleotide (NRTI)

Nucleoside analogues/NRTIs: Abacavir (ABC) ^#
Didanosine (ddI) ^◊
Emtricitabine (FTC)
Lamivudine (3TC) ^#
Stavudine (d4T) ^◊
Zalcitabine (ddC) ^‡
Zidovudine (AZT, ZDV) ^#
Amdoxovir ^†
Apricitabine ^†
Censavudine ^†
Elvucitabine ^†
Islatravir (EFdA, ISL) ^§
Racivir ^†
Stampidine ^†

Non-nucleoside (NNRTI)
(Discovery and development)

1^st generation	Efavirenz (EFV) ^# Nevirapine (NVP) ^# Delavirdine (DLV) ^‡
2^nd generation	diarylpyrimidines Dapivirine (DPV) Etravirine (ETR) Rilpivirine (RPV) Doravirine (DOR) Elsulfavirine (ESV)

Combined formulations

Pharmacokinetic boosters

Cobicistat (c)
Ritonavir (r) ^#

Experimental agents

Uncoating inhibitors	TRIM5alpha (gene)
Transcription inhibitors	Tat antagonists
Translation inhibitors	Trichosanthin
BNAbs	Elipovimab
Other	Abzyme BIT225 ^† Calanolide A Ceragenin Cyanovirin-N Diarylpyrimidines Epigallocatechin gallate (EGCG) Foscarnet Fosdevirine ^† Griffithsin Hydroxycarbamide KP-1461 ^† Miltefosine North-methanocarbathymidine Portmanteau inhibitors Scytovirin Seliciclib ^† Synergistic enhancers Tre recombinase Zinc finger protein transcription factor
Failed agents	Aplaviroc Atevirdine Brecanavir Capravirine Dexelvucitabine Droxinavir Lasinavir Emivirine Lersivirine Lodenosine Loviride Mozenavir Palinavir Telinavir

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

°DHHS recommended initial regimen options. ^◊Formerly or rarely used agent.

v
t
e

Immune sera and immunoglobulins (J06)

Polyclonal antibodies

IVIG	Anthrax immune globulin Rho(D) immune globulin Hepatitis B immune globulin Zoster-immune globulin
Antiserum	Antivenom

Monoclonal antibodies

v
t
e

Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07)

Development

Classes

Conjugate
Inactivated
Live
- Attenuated
- Heterologous
Subunit/component / Peptide / Virus-like particle / Synthetic
DNA / mRNA
Therapeutic
Toxoid

Administration

Global:
- GAVI Alliance
- NITAG
- SAGE
- Vaccine wastage
- Policy
- Schedule
- Vaccine injury
US:

Vaccines

Bacterial	Anthrax Brucellosis Cholera ^# Diphtheria ^# Hib ^# Leptospirosis Lyme disease ^‡ Meningococcus ^# MeNZB NmVac4-A/C/Y/W-135 Pertussis ^# Plague Pneumococcal ^# PCV PPSV Q fever Tetanus ^# Tuberculosis BCG ^# Typhoid ^# Ty21a ViCPS Typhus combination: DPT/DTwP/DTaP Td/Tdap research: Clostridioides difficile Group B streptococcal disease Shigellosis
Viral	Adenovirus Chikungunya Ebola rVSV-ZEBOV Flu ^# H1N1 (Pandemrix) H5N1 H5N8 LAIV Hantavirus Hepatitis A ^# Hepatitis B ^# Hepatitis E HPV ^# Cervarix Gardasil Japanese encephalitis ^# Measles ^# Mpox Mumps ^# Polio ^# Sabin Salk Rabies ^# Rotavirus ^# Rubella ^# SARS-CoV-2 Corbevax ^† Bharat Biotech ^† CanSino ^† CoronaVac ^† EpiVacCorona ^† Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK ^† Sinopharm BIBP ^† Skycovione ^† Sputnik V ^† Valneva ^† Respiratory syncytial virus (RSV) Smallpox Tick-borne encephalitis ^# Varicella zoster Chicken pox ^# Shingles Yellow fever ^# combination: Hepatitis A and B MMR MMRV research: Cytomegalovirus Dengue ^# Epstein–Barr virus Hepatitis C Herpes simplex HIV Zika
Protozoan	Malaria RTS,S research: Trypanosomiasis
Helminthiasis	research: Hookworm Schistosomiasis
Other	Androvax (androstenedione albumin) Cancer vaccines ALVAC-CEA BCG ^# Hepatitis B ^# HPV ^# Cervarix Gardasil Prostvac NicVAX Ovandrotone albumin (Fecundin) TA-CD TA-NIC combination: DTaP-IPV/Hib DTaP-IPV-HepB DTwP-HepB-Hib Hexavalent vaccine

Inventors/
researchers

Controversy

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_J&oldid=1090020044"

See also

References